{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:42:45Z","timestamp":1785879765042,"version":"3.56.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP23fk0108590"],"award-info":[{"award-number":["JP23fk0108590"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP20fk0108410"],"award-info":[{"award-number":["JP20fk0108410"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009098","name":"The Japanese Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.isci.2025.113424","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:22:48Z","timestamp":1755876168000},"page":"113424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant"],"prefix":"10.1016","volume":"28","author":[{"given":"Michishige","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Idei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ohtaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuharu","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Ishizuka-Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamao","family":"Hisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshie","family":"Kaizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sugimoto-Ishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machie","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Koseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Shirouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9495-3547","authenticated-orcid":false,"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113424_bib1","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed."},{"key":"10.1016\/j.isci.2025.113424_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.113424_bib4","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine","volume":"386","author":"Moreira","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113424_bib5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113424_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113424_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(21)00751-9","article-title":"Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial","volume":"22","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2025.113424_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-022-00880-9","article-title":"SARS-CoV-2 variant Omicron: currently the most complete \"escapee\" from neutralization by antibodies and vaccines","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.113424_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bj.2022.04.006","article-title":"SARS-CoV-2 variants - Evolution, spike protein, and vaccines","volume":"45","author":"Chen","year":"2022","journal-title":"Biomed. J."},{"key":"10.1016\/j.isci.2025.113424_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.113424_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.113424_bib12","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000786","article-title":"TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells","volume":"3","author":"Bestle","year":"2020","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.isci.2025.113424_bib13","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113424_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.113424_bib15","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113424_bib16","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1038\/s41467-022-33911-8","article-title":"Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways","volume":"13","author":"Iwata-Yoshikawa","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.113424_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/v15020271","article-title":"TMPRSS2 is essential for SARS-CoV-2 beta and omicron infection","volume":"15","author":"Metzdorf","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2025.113424_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/v12060629","article-title":"The anticoagulant nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner","volume":"12","author":"Yamamoto","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2025.113424_bib19","doi-asserted-by":"crossref","first-page":"e00754-20","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.113424_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12879-024-09468-w","article-title":"Safety and efficacy of camostat mesylate for Covid-19: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Khan","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2025.113424_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12916-022-02518-7","article-title":"A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)","volume":"20","author":"Kinoshita","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2025.113424_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101169","article-title":"Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised phase II clinical trial","volume":"41","author":"Zhuravel","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.isci.2025.113424_bib23","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300132","article-title":"A randomized trial of nafamostat for Covid-19","volume":"2","author":"Morpeth","year":"2023","journal-title":"NEJM Evid."},{"key":"10.1016\/j.isci.2025.113424_bib24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s40262-022-01170-x","article-title":"Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative review","volume":"61","author":"Hern\u00e1ndez-Mitre","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.isci.2025.113424_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50181-6","article-title":"Efficacy of nafamostat mesylate in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Narumi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.113424_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/v13030384","article-title":"TMPRSS11D and TMPRSS13 activate the SARS-CoV-2 spike protein","volume":"13","author":"Kishimoto","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2025.113424_bib27","article-title":"Establishment and characterization of an hACE2\/hTMPRSS2 knock-in mouse model to study SARS-CoV-2","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.113424_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105361","article-title":"Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice","volume":"108","author":"Verma","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2025.113424_bib29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/d41586-022-00292-3","article-title":"Omicron's molecular structure could help explain its global takeover","volume":"602","author":"Kwon","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113424_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2023.111568","article-title":"Modelling how increased Cathepsin B\/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B\/L inhibitors","volume":"572","author":"Padmanabhan","year":"2023","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.isci.2025.113424_bib31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113424_bib32","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113424_bib33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41589-022-01059-7","article-title":"Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation","volume":"18","author":"Fraser","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2025.113424_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jb\/mvs118","article-title":"Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation","volume":"153","author":"Inouye","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.isci.2025.113424_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031351","article-title":"The transmembrane protease TMPRSS2 as a therapeutic target for COVID-19 treatmentInt","volume":"23","author":"Wettstein","year":"2022","journal-title":"J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.113424_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/v15102124","article-title":"The transmembrane protease serine 2 (TMPRSS2) non-protease domains regulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike-mediated virus entry","volume":"15","author":"Strobelt","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2025.113424_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1128\/MCB.26.3.965-975.2006","article-title":"Phenotypic analysis of mice lacking the Tmprss2-encoded protease","volume":"26","author":"Kim","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.113424_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2025.113424_bib39","doi-asserted-by":"crossref","first-page":"e00649-19","DOI":"10.1128\/JVI.00649-19","article-title":"TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes","volume":"93","author":"Limburg","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.113424_bib40","doi-asserted-by":"crossref","first-page":"e0051922","DOI":"10.1128\/mbio.00519-22","article-title":"Metalloproteinase-dependent and TMPRSS2-independent cell surface entry pathway of SARS-CoV-2 requires the Furin Cleavage Site and the S2 domain of spike protein","volume":"13","author":"Yamamoto","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.isci.2025.113424_bib41","doi-asserted-by":"crossref","first-page":"eabo6783","DOI":"10.1126\/sciadv.abo6783","article-title":"SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression","volume":"8","author":"Hashimoto","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.isci.2025.113424_bib63","article-title":"SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathways","author":"Yamamoto","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2025.113424_bib42","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1021\/acs.molpharmaceut.3c00114","article-title":"Evaluation of broad anti-coronavirus activity of autophagy-related compounds using human airway organoids","volume":"20","author":"Hashimoto","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2025.113424_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2020.12.013","article-title":"Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques","volume":"554","author":"Ishigaki","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.isci.2025.113424_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.omtn.2021.10.016","article-title":"Dual inhibition of TMPRSS2 and Cathepsin Bprevents SARS-CoV-2 infection in iPS cells","volume":"26","author":"Hashimoto","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.isci.2025.113424_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3","volume":"7","author":"Zivanov","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.isci.2025.113424_bib46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryosPArc: algorithms for rapid unsupervised cryo-em structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.113424_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"Zheng","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.113424_bib48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","article-title":"CTFFIND4: fast and accurate defocus estimation from electron micrographs","volume":"192","author":"Rohou","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.isci.2025.113424_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.isci.2025.113424_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113424_bib51","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2025.113424_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.isci.2025.113424_bib53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jmb.2016.08.019","article-title":"abYsis: Integrated Antibody Sequence and Structure-Management, Analysis, and Prediction","volume":"429","author":"Swindells","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.isci.2025.113424_bib54","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/nar\/gkq1280","article-title":"VCre\/VloxP and SCre\/SloxP: new site-specific recombination systems for genome engineering","volume":"39","author":"Suzuki","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.113424_bib55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4062\/biomolther.2020.201","article-title":"Discovery of new fusion inhibitor peptides against SARS-CoV-2 by targeting the spike S2 subunit","volume":"29","author":"Kandeel","year":"2021","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.isci.2025.113424_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2018.10.014","article-title":"Development of a simple new flow cytometric antibody-dependent cellular cytotoxicity (ADCC) assay with excellent sensitivity","volume":"464","author":"Tanaka","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2025.113424_bib57","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nmeth983","article-title":"Protein complex expression by using multigene baculoviral vectors","volume":"3","author":"Fitzgerald","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.113424_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/srep30442","article-title":"Cell-free methods to produce structurally intact mammalian membrane proteins","volume":"6","author":"Shinoda","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.113424_bib59","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1073\/pnas.88.10.4181","article-title":"Reshaping a therapeutic CD4 antibody","volume":"88","author":"Gorman","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113424_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01686-21","article-title":"Establishment of a monoclonal antibody against human NTCP that blocks hepatitis B virus infection","volume":"96","author":"Takemori","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2025.113424_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.967019","volume":"13","author":"Ishigaki","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2025.113424_bib62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajpath.2013.10.004","article-title":"Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus","volume":"184","author":"Ogiwara","year":"2014","journal-title":"Am. J. Pathol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225016852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225016852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:12:46Z","timestamp":1772914366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225016852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2589004225016852"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113424","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113424"}}